Literature DB >> 29765823

The Natural Growth Rate of Residual Juvenile Angiofibroma.

Nicholas R Rowan1, Amanda L Stapleton1,2, Molly E Heft-Neal3, Paul A Gardner4, Carl H Snyderman1,4.   

Abstract

Objectives  Examine the postoperative growth rate of residual juvenile angiofibroma (JA) in a large series of patients relative to pediatric growth parameters and other prognostic factors. Establish an algorithm for postoperative surveillance of patients with JA. Design  Retrospective case series. Setting  Tertiary referral academic center. Participants  Pediatric patients undergoing surgical resection of JA between September 2005 and June 2015. Main Outcome Measures  Postoperative recurrence and tumor growth rates. Results  Thirty-eight patients were identified with a mean follow-up of 24.1 months. Sixty-eight percent (26/34) of patients achieved gross total resection, and 32% (12/38) had persistent postoperative disease. Of those with postoperative residual tumor, all had preoperative skull base involvement and residual blood supply from the internal carotid artery following embolization. Sixty-seven percent (8/12) of patients with postoperative residual tumor demonstrated radiographic stability of disease with scans being completed approximately every 6 months. Radiographic rates of disease progression ranged from 4.1 to 9.22 mm/year. Conclusions  Patients with preoperative skull base involvement and residual vascularity following preoperative embolization are more likely to have residual postoperative disease, and a longer postoperative follow-up is warranted in these patients. Progression of residual disease occurred approximately 7.5 months postoperatively. Younger patients may be more likely to need further intervention for postoperative residual disease, and postoperative imaging at 6-month intervals appears appropriate.

Entities:  

Keywords:  Angiofibroma; endoscopy; pathology; prognosis; skull base; staging system; surgery

Year:  2017        PMID: 29765823      PMCID: PMC5951706          DOI: 10.1055/s-0037-1607419

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  6 in total

Review 1.  Exclusive endoscopic resection of juvenile nasopharyngeal angiofibroma: a systematic review of the literature.

Authors:  Nadim Khoueir; Nicolas Nicolas; Ziad Rohayem; Amine Haddad; Walid Abou Hamad
Journal:  Otolaryngol Head Neck Surg       Date:  2013-12-31       Impact factor: 3.497

Review 2.  Nasal juvenile angiofibroma: Current perspectives with emphasis on management.

Authors:  Fernando López; Asterios Triantafyllou; Carl H Snyderman; Jennifer L Hunt; Carlos Suárez; Valerie J Lund; Primož Strojan; Nabil F Saba; Iain J Nixon; Kenneth O Devaney; Isam Alobid; Manuel Bernal-Sprekelsen; Ehab Y Hanna; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2017-02-15       Impact factor: 3.147

3.  A new endoscopic staging system for angiofibromas.

Authors:  Carl H Snyderman; Harshita Pant; Ricardo L Carrau; Paul Gardner
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2010-06

4.  Endoscopic resection of juvenile angiofibromas--long term results.

Authors:  Thiemo Hofmann; Manuel Bernal-Sprekelsen; Wolfgang Koele; Pia Reittner; Erich Klein; Heinz Stammberger
Journal:  Rhinology       Date:  2005-12       Impact factor: 3.681

Review 5.  Juvenile nasopharyngeal angiofibroma: a systematic review and comparison of endoscopic, endoscopic-assisted, and open resection in 1047 cases.

Authors:  Zain Boghani; Qasim Husain; Vivek V Kanumuri; Mohemmed N Khan; Saurin Sangvhi; James K Liu; Jean Anderson Eloy
Journal:  Laryngoscope       Date:  2013-03-11       Impact factor: 3.325

6.  Juvenile nasopharyngeal angiofibroma recurrence associated with exogenous testosterone therapy.

Authors:  Sterling Riggs; Richard R Orlandi
Journal:  Head Neck       Date:  2010-06       Impact factor: 3.147

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.